Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genomic Health, Inc.

J Baker1

  • 1Genomic Health Inc., 301 Penobscot Drive, Redwood City, CA 94063, USA. joff@genomichealth.com

Pharmacogenomics
|March 30, 2007
PubMed
Summary

Genomic Health offers the Oncotype DX test, a genomic service that predicts breast cancer recurrence, survival, and chemotherapy benefit. This allows for personalized cancer treatment decisions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experiences of restrictive practices in child and adolescent mental health inpatient care: an integrative review.

Child and adolescent psychiatry and mental health·2026
Same author

1390 nm GaAs-based dilute nitride VCSELs on 150 mm wafers for scalable production.

Optics express·2026
Same author

Topographical memory in transient epileptic amnesia.

Epilepsy & behavior : E&B·2026
Same author

Co-production as the ultimate goal; an incentive or discouragement?

Research involvement and engagement·2025
Same author

Evidence of Genetic Isolation and Differentiation Among Historically Fragmented British Populations of Common Juniper, <i>Juniperus communis</i> L.

Ecology and evolution·2025
Same author

Author Correction: Electrical stimulation of smiling muscles reduces visual processing load and enhances happiness perception in neutral faces.

Communications psychology·2025

Area of Science:

  • Oncology
  • Genomics
  • Clinical Diagnostics

Background:

  • Genomic Health, Inc. is a life science company.
  • Focuses on genomic-based clinical laboratory services for cancer patients.
  • Aims to enable individualized treatment decisions.

Purpose of the Study:

  • To introduce Oncotype DX, a diagnostic multigene expression test.
  • To validate its ability to predict breast cancer recurrence.
  • To assess its utility in predicting patient survival and chemotherapy benefit.

Main Methods:

  • Extensive evaluation of Oncotype DX.
  • Multiple independent studies involving over 2600 breast cancer patients.
  • Rigorous validation studies were conducted.

Main Results:

  • Oncotype DX demonstrated clinical evidence for predicting breast cancer recurrence.
  • The test can predict patient survival within 10 years of diagnosis.
  • It also predicts the likelihood of chemotherapy benefit.

Conclusions:

  • Oncotype DX provides valuable prognostic and predictive information for breast cancer.
  • Genomic testing enables personalized treatment strategies.
  • Genomic Health aims to expand similar tests to other cancer types.

Related Experiment Videos